Catalyst Pharmaceuticals filed new patent infringement lawsuits against Jacobus Pharmaceuticals and PANTHERx Rare LLC over a treatment for the rare autoimmune disease Lambert-Eaton Myasthenic Syndrome (LEMS).
U.S. presidential candidate Bernie Sanders proposed spending $1.5 trillion over 10 years to create a universal child care and early education system, to be funded by taxing the wealthiest Americans.
Florida-based Catalyst Pharmaceuticals is attempting to show in court that the price of a newly approved treatment for a rare autoimmune disease and pressure from U.S. Sen. Bernie Sanders lead to the approval of a rival treatment.
U.S. President Donald Trump will unveil an executive order aimed at strengthening Medicare for seniors, seeking to improve the health program’s fiscal position and offer more affordable plan options, administration officials said.
U.S. Senator Bernie Sanders unveiled the latest version of his ambitious “Medicare-for-All” plan, moving the healthcare debate among Democratic presidential contenders to center stage in the 2020 race.
The reality of a President-elect Donald Trump has been a shot in the arm for pharma and biotech leaders’ stock prices as they surged in U.S. and European markets.